DGX

Quest Diagnostics Incorporated

Healthcare


Presented:10/17/2014
Price:$58.81
Cap:$6.00B
Current Price:$149.35
Cap:$16.63B

Presented

Date10/17/2014
Price$58.81
Market Cap$6.00B
Ent Value$6.23B
P/E Ratio18.39x
Book Value$29.87
Div Yield2.2%
Shares O/S50.27M
Ave Daily Vol460,000
Short Int10.27%

Current

Price$149.35
Market Cap$16.63B
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, water testing, and dairy markets worldwide. The company operates through Companion Animal Group, Water, Livestock and Poultry Diagnostics, Dairy, and OPTI Medical segments. The company primary offers point-of-care veterinary diagnostic products comprising instruments and consumables, and rapid assays; veterinary reference laboratory diagnostic and consulting services; and practice management systems and services, and digital radiography systems used by veterinarians. It also provides biological materials testing and laboratory diagnostic instruments and services used by the biomedical research community; diagnostic and health-monitoring products for livestock and poultry; products that test water for certain microbiological contaminants; products that test milk for antibiotic residues and other contaminants; and point-of-care electrolytes and blood gas analyzers used in the human point-of-care medical diagnostics market. The company markets and sells its products through marketing, sales, and technical service groups, as well as independent distributors and other resellers. IDEXX Laboratories, Inc. was founded in 1983 and is headquartered in Westbrook, Maine.

Publicly traded companies mentioned herein: Illumina Inc (ILMN), Laboratory Corp of America Holdings (LH), Quest Diagnostics Inc (DGX)

Highlights

Shares of Quest Diagnostics (DGX) are up this year (~10%), but the company’s fundamentals have not improved and the presenter can’t reconcile why DGX’s multiple seems to have re-rated higher. Regardless, the presenter is short and believes a trifecta of issues will ultimately lead to a decline in the stock price.

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Request access to DeMatteo Research for full access

Request Access

Already have an account?

Idea Discussion

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Idea Discussions display submitted commentary from our investor community.

To read and participate in the discussion with the presenter and investor base, request access to DeMatteo

Request Access

Already have an account?

An error occurred loading this content. Try again later or contact us.